{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:17:00Z","timestamp":1768745820723,"version":"3.49.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>The number of confirmed COVID-19 cases is rapidly increasing with no direct treatment for the disease. Few repurposed drugs, such as Remdesivir, Chloroquine, Hydroxychloroquine, Lopinavir, and Ritonavir, are being tested against SARS-CoV-2. Remdesivir is the drug of choice for Ebola virus disease and has been authorized for emergency use. This drug acts against SARS-CoV-2 by inhibiting the RNA-dependent-RNA-polymerase (RdRp) of SARS-CoV-2. RdRp of viruses is prone to mutations that confer drug resistance. A recent study by Pachetti et al. in 2020 identified the P323L mutation in the RdRp protein of SARS-CoV-2. In this study, we aimed to determine the potency of lead compounds similar to Remdesivir, which can be used as an alternative when variants of SARS-CoV-2 develop resistance due to RdRp mutations. The initial screening yielded 704 compounds that were 90% similar to the control drug, Remdesivir. On further evaluation through drugability and antiviral inhibition percentage analyses, we shortlisted 32 and seven compounds, respectively. These seven compounds were further analyzed for their molecular interactions, which revealed that all seven compounds interacted with RdRp with higher affinity than Remdesivir under native conditions. However, three compounds failed to interact with the mutant protein with higher affinity than Remdesivir. Dynamic cross-correlation matrix (DCCM) and vector field collective motions analyses were performed to identify the precise movements of docked complexes' residues. Furthermore, the compound SCHEMBL20144212 showed a high affinity for native and mutant proteins and might provide an alternative against SARS-CoV-2 variants that might confer resistance to Remdesivir. Further validations by <jats:italic>in vitro and in vivo<\/jats:italic> studies are needed to confirm the efficacy of our lead compounds for their inhibition against SARS-CoV-2.<\/jats:p>","DOI":"10.3389\/fmolb.2021.645216","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T06:55:06Z","timestamp":1617951306000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2"],"prefix":"10.3389","volume":"8","author":[{"given":"Thirumal","family":"Kumar D","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishaat","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udhaya","family":"Kumar S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Priya","family":"Doss C","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"MBio"},{"key":"B2","doi-asserted-by":"publisher","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/3-540-26765-4_1","article-title":"Coronavirus genome structure and replication","volume":"287","author":"Brian","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"12359","DOI":"10.1128\/JVI.75.24.12359-12369.2001","article-title":"Reverse genetics system for the avian coronavirus infectious bronchitis virus","volume":"75","author":"Casais","year":"2001","journal-title":"J. Virol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.virol.2005.02.017","article-title":"Expression, purification, and characterization of SARS coronavirus RNA polymerase","volume":"335","author":"Cheng","year":"2005","journal-title":"Virology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1000896","article-title":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing","volume":"6","author":"Eckerle","year":"2010","journal-title":"PLoS Pathog."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/nm.3362","article-title":"Treatment with interferon-\u03b12b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","volume":"19","author":"Falzarano","year":"2013","journal-title":"Nat. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1128\/JVI.70.7.4683-4690.1996","article-title":"Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein","volume":"70","author":"Gallagher","year":"1996","journal-title":"J. Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jmv.25699","article-title":"The first two cases of 2019-nCoV in Italy: where they come from?","volume":"92","author":"Giovanetti","year":"2020","journal-title":"J. Med. Virol."},{"key":"B11","first-page":"197","article-title":"Genome similarities between plant and animal RNA viruses","volume":"4","author":"Goldbach","year":"1987","journal-title":"Microbiol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1093\/bioinformatics\/btl461","article-title":"Bio3d: an R package for the comparative analysis of protein structures","volume":"22","author":"Grant","year":"2006","journal-title":"Bioinformatics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14586","DOI":"10.1021\/bi0510429","article-title":"Conformational dynamics of M2 helices in KirBac channels: helix flexibility in relation to gating via molecular dynamics simulations","volume":"44","author":"Grottesi","year":"2005","journal-title":"Biochemistry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1042\/bst0151009","article-title":"Flexibility and rigidity, requirements for the function of proteins and protein pigment complexes","volume":"15","author":"Huber","year":"1987","journal-title":"Eleventh Keilin Memorial Lecture"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1111\/febs.13343","article-title":"Rigidity versus flexibility: the dilemma of understanding protein thermal stability","volume":"282","author":"Karshikoff","year":"2015","journal-title":"FEBS J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e9180","DOI":"10.1371\/journal.pone.0009180","article-title":"Conformational dynamics and ligand binding in the multi-domain protein PDC109","volume":"5","author":"Kim","year":"2010","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/10409239309078440","article-title":"Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences","volume":"28","author":"Koonin","year":"1993","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"B22","doi-asserted-by":"publisher","first-page":"W374","DOI":"10.1093\/nar\/gkx385","article-title":"DynOmics: dynamics of structural proteome and beyond","volume":"45","author":"Li","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1126\/science.abb3221","article-title":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)","volume":"368","author":"Li","year":"2020","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00399-20","article-title":"Compounds with therapeutic potential against novel respiratory 2019 Coronavirus","volume":"64","author":"Martinez","year":"2020","journal-title":"Antimicrob. Agents Chemotherap."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"Chembiochem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02344-6","article-title":"Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant","volume":"18","author":"Pachetti","year":"2020","journal-title":"J. Transl. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1056\/NEJMc2001272","article-title":"Importation and human-to-human transmission of a novel coronavirus in vietnam","volume":"382","author":"Phan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/bmj.317.7159.660","article-title":"Antiviral drug resistance","volume":"317","author":"Pillay","year":"1998","journal-title":"Br. Med. J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/cbdd.12834","article-title":"AVCpred: an integrated web server for prediction and design of antiviral compounds","volume":"89","author":"Qureshi","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"B33","first-page":"41","article-title":"The gaussian network model: theory and applications","volume-title":"Normal Mode Analysis Theory and Applications to Biological and Chemical Systems","author":"Rader","year":"2005"},{"key":"B34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1830177","article-title":"Mutational landscape of K-Ras substitutions at 12th position-a systematic molecular dynamics approach","volume":"120","author":"S","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e1003329","DOI":"10.1371\/journal.pcbi.1003329","article-title":"Mapping the structural and dynamical features of kinesin motor domains","volume":"9","author":"Scarabelli","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.mi.42.100188.003301","article-title":"Evolution of RNA viruses","volume":"42","author":"Strauss","year":"1988","journal-title":"Annu. Rev. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.1128\/JVI.75.14.6676-6681.2001","article-title":"Viral replicase gene products suffice for coronavirus discontinuous transcription","volume":"75","author":"Thiel","year":"2001","journal-title":"J. Virol."},{"key":"B40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/bs.apcsb.2019.11.004","article-title":"Chapter Eight - Comprehensive in silico screening and molecular dynamics studies of missense mutations in Sjogren-Larsson syndrome associated with the ALDH3A2 gene","volume-title":"Advances in Protein Chemistry and Structural Biology Inflammatory Disorders - Part B","author":"Udhaya Kumar","year":"2020"},{"key":"B41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/1389200217666151210141903","article-title":"Intracellular metabolism of nucleoside\/nucleotide analogues: a bottleneck to reach active drugs on HIV reverse transcriptase","volume":"17","author":"Varga","year":"2016","journal-title":"Curr. Drug Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/2020.04.08.032763","article-title":"Structural basis for the inhibition of the RNA-Dependent RNA polymerase from SARS- CoV-2 by Remdesivir","volume":"1560","author":"Wanchao","year":"2020","journal-title":"bioRxiv"},{"key":"B44","doi-asserted-by":"publisher","first-page":"hvaa080","DOI":"10.1093\/clinchem\/hvaa080","article-title":"The SARS-CoV-2 outbreak: diagnosis, infection prevention, and public perception","volume":"66","author":"Wang","year":"2020","journal-title":"Clin. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"B46","unstructured":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV)"},{"key":"B47","unstructured":"WHO Director-General's Remarks at the Media Briefing on 2019-nCoV on 11 February 2020"},{"key":"B48","unstructured":"Coronavirus Update (Live)2021"},{"key":"B49","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/v12020244","article-title":"Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV","volume":"12","author":"Xu","year":"2020","journal-title":"Viruses"},{"key":"B50","doi-asserted-by":"publisher","first-page":"7117","DOI":"10.1093\/nar\/gkg916","article-title":"Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design","volume":"31","author":"Xu","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.str.2007.12.011","article-title":"Close correspondence between the motions from principal component analysis of multiple HIV-1 protease structures and elastic network modes","volume":"16","author":"Yang","year":"2008","journal-title":"Structure"},{"key":"B52","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/jmv.25729","article-title":"A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option","volume":"92","author":"Yao","year":"2020","journal-title":"J. Med. Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2021.645216\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T06:55:14Z","timestamp":1617951314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2021.645216\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":54,"alternative-id":["10.3389\/fmolb.2021.645216"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2021.645216","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]},"article-number":"645216"}}